Brief: Windtree Therapeutics Quarterly Net Loss $13.01 Per Share
April 3 (Reuters) - Windtree Therapeutics Inc WINT.O :
* WINDTREE THERAPEUTICS INC - QTRLY NET LOSS OF $13.01 PER
SHARE
* WINDTREE THERAPEUTICS - AS OF DECEMBER 31, 2022, REPORTED
CASH,
CASH EQUIVALENTS OF $6.2 MILLION, EXPECTED TO BE SUFFICIENT TO
FUND OPERATIONS INTO Q2 2023
Further company coverage: WINT.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Windtree Therapeutics
See all newsBrief: Windtree Therapeutics Announces It Has Signed A Letter Of Intent To Acquire Commloan
Brief: Windtree Therapeutics Announces It May Receive License Agreement Payments From Its Licensee For Renewed Acute Pulmonary Development By The Licensee
Brief: Windtree Therapeutics Stockholders Approve Key Proposals For Revenue And Profit Generation At The Special Stockholder Meeting
Brief: Windtree Therapeutics Terminates Seismic-C Clinical Study At 20 Enrollments - SEC Filing
Brief: Windtree Therapeutics Inc - Announces Interim Analysis Of Istaroxime Phase 2 Study